1. Trang chủ
  2. » Cao đẳng - Đại học

2006 diabetes vietnam compressed 12+

32 292 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 32
Dung lượng 3,89 MB

Nội dung

Fatty liver Liver Insulin resistance increased glucose output Fat Poisoning Fat Poisoning Fat + Inactivity Fatty muscles Muscle Insulin resistance Fat Poisoning Fat Poisoning Fat Poisoning Fat Poisoning Beta cell failure Inadequate insulin To counter Insulin resistance Hyperglycaemia Sugar Poisoning Sugar Poisoning Beta-cell failure • Ectopic deposition of fat in the islet cells leads to Beta-cell failure Burned-out Pancreas INSULIN RESISTANCE TIME 11 5 7.1 Plasma Glucose Impaired glucose tolerance Ausdiab 10.6 % population 1.3 million Australians NIDDM FPG >7; 2hr >11 INSULIN Beta cell failure Insulin resistance combined with beta-cell dysfunction 6.1 Treat B-cell failure & Insulin resistance Multi-target treatment Multi-target treatment Central obesity Vascular-thrombotic Complications β-Cell Preservation Insulin Resistance Micro-vascular Complications Insulin Secretion + INSULIN + INSULIN +/or Glitazones DIET+ EXERCISE DIET+ EXERCISE Management of Diabetes Twice Daily Twice Daily Sulphonylurea Sulphonylurea Metformin Metformin + WT loss Drugs + WT loss Drugs Reductil Acomplia Once Daily Once Daily Sulphonylurea Sulphonylurea Amaryl 0 0.5 1 1.5 2 2.5 3 100 10 1 0 2.5 5 10 20 Glimepiride Concentration ( µ mol/L) Glucose (mmol/L) Insulin secretion* ( µ U/islet/45min) Del Guerra et al. Acta Diabetol 2000;37:139. *Isolated human pancreatic islets Amaryl: Physiologic Insulin Secretion Dependent on Glucose Concentration Responsiveness of Sulfonylureas to Changing Glucose Concentrations Insulin secretion (% of cell content) Design: • Incubation of human islets for 24 h with different sulfonylureas • Glucose stimulus for 45min 3.3mM glucose (dark shade) and 16.7mM (light shade) * P < .01 † P < .05 * Del Guerra et al. submitted to EASD 2001. ns Gp = Glimepiride; Gb = glibenclamide; Chl = Chlorpropamide 0 1 2 3 4 5 6 Control Gp 10?M Gb 10?M Chl 600?M [...]... obesity Macro-vascular •Lipids •Thrombosis •Inflammation Value of weight loss • Risk of type 2 diabetes greatly reduced by substantive weight loss • Weight loss can achieve reversion to normal glucose tolerance • Diabetes Prevention Program showed lifestyle intervention (diet + exercise) reduced the incidence of diabetes by 58% (vs controls) Reward system • Endocannabinoid system involved in incentive... combination + basal insulin uptitration HbA1c (%) 10 9 8 7 6 Duration of diabetes OAD + multiple daily insulin injections Proactive management of glycaemia: early combination approach Diet OAD monotherapy 10 OAD combinations HbA1c (%) OADs uptitration 9 OAD + basal insulin OAD + multiple daily insulin injections 8 7 6 Duration of diabetes Steno 2 trial • 8 yr study of 160 diabetics + microalbuminuria... insulin sensitivity …ineglucos tolerant, insulin -resistant offspring of patients with type 2 diabetes. ” Volk et al.Diabetologia 2000;43(suppl 1):A39 Glycaemic goals • • • • Fasting plasma glucose . Complications Insulin Secretion + INSULIN + INSULIN +/or Glitazones DIET+ EXERCISE DIET+ EXERCISE Management of Diabetes Twice Daily Twice Daily Sulphonylurea Sulphonylurea Metformin Metformin + WT loss Drugs +. Day With Once-Daily Glimepiride Amaryl 8am 12 noon 6pm 10pm 2 am 24 Hours Patients with type 2 diabetes 0.43 episodes/1000 person-years vs 5.8 episodes/1000 person- years glimepiride fewer. Glipizide Glimepiride Phase III clinical data showed a trend toward weight neutrality Bugos et al. Diabetes Res Clin Pract 2000;50 (suppl 1). *Meta-analysis of data from 4 studies Mean Change in

Ngày đăng: 12/08/2014, 20:59

w